BioCentury | May 23, 2011
Clinical News

Aplenzin bupropion hydrobromide regulatory update

...for smoking cessation. Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX), Mississauga, Ontario Product: Aplenzin bupropion hydrobromide (formerly BVF-033...
BioCentury | Apr 19, 2010
Company News

sanofi-aventis pharmaceuticals news

...Aplenzin bupropion to a contract organization. sanofi-aventis has U.S. and Puerto Rican rights to market Aplenzin...
BioCentury | Apr 13, 2009
Company News

Biovail, sanofi-aventis sales and marketing update

...sanofi-aventis' sanofi-aventis U.S. unit launched once-daily Aplenzin bupropion in the U.S. to treat major depressive disorder...
...and 522 mg tablets. sanofi-aventis has rights to market the alcohol-resistant formulation of bupropion (formerly BVF-033...
BioCentury | Feb 2, 2009
Clinical News

Zoloft sertraline neurology data

...Alto, Calif.) markets Luvox CR fluvoxamine; GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) markets Paxil paroxetine; Aplenzin...
BioCentury | Jan 5, 2009
Company News

Biovail, J&J, sanofi-aventis sales and marketing update

...therapy for several days or more. Separately, sanofi-aventis will market Biovail's once-daily Aplenzin bupropion hydrobromide (formerly BVF-033...
BioCentury | Sep 29, 2008
Regulation

Acting on REMS

...tetrabenazine Prestwick P P P Other approvals/actions Advair salmeterol/fluticasone propionate GlaxoSmithKline (LSE:GSK; NYSE:GSK) P Aplenzin bupropion hydrobromide...
BioCentury | Apr 28, 2008
Clinical News

Aplenzin bupropion hydrobromide regulatory update

...FDA approved an NDA from Biovail for once-daily Aplenzin bupropion hydrobromide (formerly BVF-033) to treat depression in...
...NDA with new analysis of the data. Biovail is currently seeking a U.S. commercialization partner. Aplenzin...
...of bupropion, an atypical antipsychotic. Biovail Corp. (TSX:BVF; NYSE:BVF), Mississauga, Ontario Product: Aplenzin bupropion hydrobromide (formerly BVF-033...
BioCentury | Apr 7, 2008
Finance

2Q milestones

...2Q08 BioSpecifics (OTCBB:BSTC)/Auxilium (NASDAQ:AUXL) Xiaflex (AA4500) Dupuytren's disease Ph III data 2Q08 Biovail (TSX:BVF; NYSE:BVF) BVF-033...
BioCentury | Dec 3, 2007
Clinical News

BVF-033 regulatory update

...FDA accepted a complete response from BVF to a July not approvable letter for BVF-033 to...
...BVF-033 is a once-daily, alcohol-resistant formulation of bupropion. Biovail Corp. (TSX:BVF; BVF), Mississauga, Ontario Product: BVF-033...
BioCentury | Oct 29, 2007
Finance

Ebb & Flow

...the company said it submitted a complete response to a July not approvable letter for BVF-033...
Items per page:
1 - 10 of 16